Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:59 PM
Ignite Modification Date:
2025-12-24 @ 7:59 PM
NCT ID:
NCT01677104
Eligibility Criteria:
Inclusion Criteria:
* Lean BMI ≤ 25.0 kg/m2
* Obese BMI ≥30.0kg/m2
* Non diabetic subjects and subjects with Type 2 diabetes on stable medication for at least 3 months
Exclusion Criteria:
* cardiovascular disease
* Raynaud's disease
* current treatment with any anti-hypertensive
* lipid lowering therapies
* severe hepatic impairment
* pregnancy and lactation
* subjects with Type 2 diabetes on insulin therapy
* subjects with Type 2 diabetes on sulphonylureas
* subjects with Type 2 diabetes on incretin based therapies
* subjects with Type 2 diabetes and peripheral vascular disease
* subjects with Type 2 diabetes and history of advanced retinopathy
* subjects with Type 2 diabetes and advanced nephropathy
* subjects with Type 2 diabetes with uncontrolled diabetes (HbA1c \> 8.5%)
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01677104
Study Brief:
Protocol Section:
NCT01677104